Somerset Trust’s Bristol-Myers Squibb BMY Stock Holding History

Somerset Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-200	Closed	-$13K	–	158
2015 Q1	$13K	Hold	200	–	–	0.01%	168
2014 Q4	$12K	Hold	200	–	–	0.01%	167
2014 Q3	$10K	Hold	200	–	–	0.01%	170
2014 Q2	$10K	Hold	200	–	–	0.01%	170
2014 Q1	$10K	Sell	200 -1,000	-83%	-$53.2K	0.01%	172
2013 Q4	$64K	Buy	+1,200	New	+$61.1K	0.05%	133

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Somerset Trust's BMY Position: Q2 2015 in Review

Somerset Trust sold out of Bristol-Myers Squibb (BMY) in Q2 2015, closing a stake of 200 shares — an estimated $13K sold.

Somerset Trust first reported a position in BMY in Q4 2013 and held it in 6 quarters. The position peaked at $64K in Q4 2013. 1,447 funds tracked by Wall St. Rank hold BMY as of Q2 2015.

Somerset Trust reported no remaining Bristol-Myers Squibb position as of Q2 2015 after selling out during the quarter.
Somerset Trust sold 200 Bristol-Myers Squibb shares in Q2 2015, an estimated $13K.
Somerset Trust first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 6 quarters.
Somerset Trust's Bristol-Myers Squibb position peaked at $64K in Q4 2013.
1,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2015.

Based on Somerset Trust's 13F filing for Q2 2015, filed 14 Jul 2015.